Izon Science enables nanoparticle researchers across a range of disciplines to isolate and characterise particles with precision. With the field of extracellular vesicles (EVs) now pushing towards clinical applications, Izon is meeting the need for scalable EV isolation solutions for EV-based diagnostics and EV-based therapeutics, as well as fundamental EV research. 
This is achieved through its evolving range of size exclusion chromatography-based qEV columns, associated instrumentation for automating particle isolation, and customised bioprocessing development services. With such diverse customers, the qEV platform accommodates a broad range of sample types and volumes.  
Meanwhile, Izon brings high-resolution insights to the physical characterisation of EVs, lipid nanoparticles, viruses and beyond, through the Exoid and its Tunable Resistive Pulse Sensing (TRPS) technology. Through its unique particle-by-particle approach, the Exoid allows researchers across fundamental research and nanomedicine development to measure particle size, concentration, and zeta potential.
Izon’s network is global, with offices located in Christchurch (New Zealand – Headquarters), Lyon (France), Boston and Texas (US). 

Life Sciences

Biotechnology

Izon Science

Izon Science's headquarters in Christchurch, New Zealand

Description

People (1)

Ashley Stewart

Jobs